Noom

Weight loss is about more than just the number on the scale — it’s also about how you feel. In The Atlantic, Mikala Jamison explores the relationship between weight loss and mental health, and why emotional wellbeing deserves more attention as GLP-1s reshape weight care. At Noom, that idea isn’t new. Psychology and behavior change have long shaped how we support our members. That includes helping people manage stress, understand their relationship with food, and make room for moments of calm in everyday life. That’s why we’re building experiences that go beyond food and the scale. The Atlantic highlights Noom’s Mindful Art Break, which invites members to pause with works of art and reflect. As one member shared in the piece, it helped them “contemplate something other than weight loss.” It’s just one way we’re making emotional wellbeing part of the everyday Noom experience, alongside tools like breathwork and meditation. Supporting lasting change means paying attention to the whole person, including their emotional wellbeing. Thanks to Mikala C. J. for exploring this connection and including Noom in the conversation. Read the full piece: https://lnkd.in/dHTHaESQ

Noom CEO Geoff Cook joined health and tech leaders in Washington, DC, this week to discuss making care more accessible and helping patients take a more active role in their health. His message: behavior change, telehealth, diagnostics, wearables, and AI are converging into a single experience, and that convergence is what will finally make whole-person care the standard. Noom’s piece of it is shaping the moments between treatment — the small choices people make every day. That's the work Noom has done for 15 years: helping people turn health advice into behaviors they can actually sustain. And it’s where Geoff sees healthcare heading, as new models like CMS ACCESS begin to show what more continuous, whole-person, outcomes-based care could look like at scale. The summit brought together leaders from across health and technology, including Anthropic, OpenAI, Function Health, hims & hers, ŌURA, WHOOP, and others. Watch Geoff's remarks: https://lnkd.in/guNCHJHg

Last week, Noom Chief Medical Officer Dr. Jeffrey Egler delivered a keynote at UC San Diego’s AI and Healthy Aging Symposium about a challenge at the center of the longevity industry: how do we translate information on what it takes to age well into healthier behaviors and habits that stick? Dr. Egler called it “the last mile of longevity science.” One line from the talk: “A map is not a vehicle.” Better measurement can tell us where we are. It doesn’t automatically help us build the habits that move us forward. Dr. Egler also looked at where AI could help close that gap. The evidence isn’t as simple as ‘AI works.’ One study he shared found that adding an AI assistant alone didn’t improve medication adherence; but sustained engagement with Noom’s companion app was closely tied to improved outcomes while on GLP-1s. It’s an important distinction, and one we think about a lot at Noom: how can technology make healthy behaviors easier to start and easier to sustain? AI isn’t the intervention itself. What matters is whether it helps people stay engaged long enough for those habits to take hold. Thank you to the UCSD Stein Institute for Research on Aging for bringing together researchers, clinicians, trainees and more for a thoughtful conversation. #HealthyAging #Longevity

Last week, Noom CEO Geoff Cook joined Taylor Kantor, MD, co-founder of Ivim Health, at the inaugural PepMed Congress in Washington, D.C. for a panel on “How to Do Peptides Right,” moderated by Lee Rosebush, PharmD, JD, Chairman of AAPM. Noom’s point of view is simple: medication can be the spark, but it shouldn’t be the whole journey. As Geoff put it: “Our GLP-1 experience gives us a template for peptides: clinician-guided care, high-quality pharmacy standards, strong adverse-event reporting, and clear accountability across the care chain.” A few other themes from the conversation: → Behavior change is what makes progress more durable. GLP-1s can create a window when healthier choices become easier. The opportunity is to use that momentum to build habits that can last beyond the medication. → Responsible care requires real infrastructure. As peptide interest grows, safety, sourcing, clinical oversight, and transparency have to grow with it. → Access should mean more than access to a prescription. As medications become more affordable, the next opportunity is expanding access to the lifestyle and behavior-change support that helps people turn treatment into better long-term health. Thank you to AAPM, Taylor, Lee, and the PepMed team for convening an important conversation. The future of preventive health isn’t medication or behavior. It’s both. #Peptides #GLP1 #DigitalHealth #PreventiveHealth #Noom

When it comes to talent retention, flexibility can no longer be considered a perk. It's what's expected from today's talent. Registered dietician and relationships lead at Noom Health, Elizabeth Entin, MPH, RD, LDN, dove into this topic at HR Brew's Total Rewards Equation event today, joining other experts in a panel discussion on "The Flexibility Factor: Strategic Benefits for Employee Wellbeing". The conversation explored how leading organizations are redesigning total rewards to support employees across mental, financial, and social wellbeing, emphasizing that flexibility should meet people where they actually are, not where a one-size-fits-all policy assumes they are. That's the same thinking behind how we approach behavior change at Noom Health, meeting members with support that flexes to their real life. Thanks to HR Brew for convening this conversation, and to Liz for representing Noom Health on stage!

We’re excited to share that two Noom experiences have been honored by Fast Company’s 2026 Innovation by Design Awards: Mindful Art Break in Experience Design and AI Face Scan in Health and Wellness Design. Both reflect a question that guides how we build at Noom: how can we make caring for your health easier to put into practice? Mindful Art Break brings fine art and guided reflection into a two-minute pause, helping members make space for calm, focus, and mental wellbeing. AI Face Scan turns a 30-second scan using a smartphone camera into insights about measures such as heart rate, stress, and estimated biological age, making information about personal wellbeing more accessible. These experiences bring together science, technology, and design to support the whole person and make small steps toward better health feel approachable. Thank you to Fast Company for the recognition, and to the Noom teams whose curiosity and care bring these ideas to life for our members. Congrats to all the honorees! See the full list of honorees: https://lnkd.in/ePbEBrST Best in Health & Wellness Design: https://lnkd.in/gS_6yEpe Best in Experience Design: https://lnkd.in/gG7MWSQ9

What if the biggest opportunity in GLP-1 treatment isn’t the weight loss, but the window it creates to build habits that last? A new peer-reviewed Viewpoint in the Journal of Medical Internet Research, authored by Noom CEO Geoff Cook, explores that idea. GLP-1s can produce substantial weight loss. But persistence remains a challenge, and weight can return quickly after treatment ends. The paper asks whether the time on treatment may create a unique opportunity for behavior change. The hypothesis starts with “food noise.” In one survey of semaglutide users, constant food-related thoughts fell from 62% before treatment to 16% after starting medication. With less cognitive burden, and the “fresh start” of beginning treatment, healthier choices may become easier to turn into routines. That’s the potential role of a GLP-1 companion: not replacing medication, but helping turn its biological effects into behavioral changes that may last longer. The paper applies Social Cognitive Theory and Behavioral Economics to medication persistence, side-effect management and durable health behaviors, many of which are already built into Noom’s GLP-1 Companion. That’s how we build at Noom: start with the science, turn it into better support for members, and keep testing what works. Read the JMIR paper: https://lnkd.in/e4y_3YfJ Read Geoff’s perspective on the Noom blog: https://lnkd.in/eEdiG2-i

Excited to officially welcome James Bugden as Noom's Chief Financial Officer. Jim brings deep experience scaling high-growth technology and consumer companies. As Noom continues building out its clinical platform and expanding into new categories, Jim's financial and operational leadership is an important addition to the team. Welcome, Jim! Read more here: https://lnkd.in/gsRDm6c5

We're hearing the term "food noise" a lot more these days, but the science behind what's actually happening in the brain is still catching up. It's great to see other researchers referencing our CEO Geoff Cook's research in Cureus Journal of Medical Science, which digs into the mechanisms behind something so many people are feeling. At Noom, we see "quieting the noise" play out every day in how people experience behavior change alongside GLP-1 medications. Worth a read for anyone thinking about the psychology behind lasting change: https://lnkd.in/euQqRVgU